SinoMab BioScience Dirección
Dirección controles de criterios 3/4
SinoMab BioScience's CEO is Shawn Leung, appointed in Jan 2001, has a tenure of 23.83 years. total yearly compensation is CN¥5.11M, comprised of 99.7% salary and 0.3% bonuses, including company stock and options. directly owns 11.88% of the company’s shares, worth HK$167.35M. The average tenure of the management team and the board of directors is 3 years and 4.9 years respectively.
Información clave
Shawn Leung
Chief Executive Officer (CEO)
CN¥5.1m
Compensación total
| Porcentaje del salario del CEO | 99.7% |
| Permanencia del CEO | 23.8yrs |
| Participación del CEO | 11.9% |
| Permanencia media de la dirección | 3yrs |
| Promedio de permanencia en la Junta Directiva | 4.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Update: SinoMab BioScience (HKG:3681) Stock Gained 21% In The Last Year
Mar 04
What You Need To Know About SinoMab BioScience Limited's (HKG:3681) Investor Composition
Jan 28Did SinoMab BioScience Limited (HKG:3681) Insiders Buy Up More Shares?
Jan 01
Loss-Making SinoMab BioScience Limited (HKG:3681) Expected To Breakeven In The Medium-Term
Nov 30Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥200m |
| Mar 31 2024 | n/a | n/a | -CN¥221m |
| Dec 31 2023 | CN¥5m | CN¥5m | -CN¥243m |
| Sep 30 2023 | n/a | n/a | -CN¥259m |
| Jun 30 2023 | n/a | n/a | -CN¥274m |
| Mar 31 2023 | n/a | n/a | -CN¥279m |
| Dec 31 2022 | CN¥5m | CN¥5m | -CN¥284m |
| Sep 30 2022 | n/a | n/a | -CN¥301m |
| Jun 30 2022 | n/a | n/a | -CN¥318m |
| Mar 31 2022 | n/a | n/a | -CN¥303m |
| Dec 31 2021 | CN¥4m | CN¥4m | -CN¥288m |
| Sep 30 2021 | n/a | n/a | -CN¥222m |
| Jun 30 2021 | n/a | n/a | -CN¥156m |
| Mar 31 2021 | n/a | n/a | -CN¥139m |
| Dec 31 2020 | CN¥5m | CN¥4m | -CN¥123m |
Compensación vs. Mercado: Shawn's total compensation ($USD719.96K) is above average for companies of similar size in the Hong Kong market ($USD359.95K).
Compensación vs. Ingresos: Shawn's compensation has been consistent with company performance over the past year.
CEO
Shawn Leung (64 yo)
23.8yrs
Permanencia
CN¥5,106,000
Compensación
Dr. Shui On Leung, also known as Shawn, serves as Chief Executive Officer of SinoMab BioScience Limited since January 2003 and also serves as its Director and Chairman of the Board since April 27 2001 and...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 23.8yrs | CN¥5.11m | 11.88% HK$ 167.4m | |
| Chief Financial Officer | 5.8yrs | sin datos | sin datos | |
| Director of Marketing | 1.8yrs | sin datos | sin datos | |
| Chief Medical Officer | 3.3yrs | sin datos | sin datos | |
| President of China & Executive Director | 2.8yrs | sin datos | 1.19% HK$ 16.7m | |
| Company secretary | 1.7yrs | sin datos | sin datos |
3.0yrs
Permanencia media
54.5yo
Promedio de edad
Equipo directivo experimentado: 3681's management team is considered experienced (3 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 23.6yrs | CN¥5.11m | 11.88% HK$ 167.4m | |
| President of China & Executive Director | less than a year | sin datos | 1.19% HK$ 16.7m | |
| Independent Non-Executive Director | 5.1yrs | CN¥283.00k | sin datos | |
| Non-Executive Director | 7.3yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 5.1yrs | CN¥283.00k | sin datos | |
| Non-Executive Director | 4.9yrs | sin datos | sin datos | |
| Independent Non Executive Director | 4.9yrs | CN¥283.00k | sin datos | |
| Independent Non-Executive Director | 3.4yrs | CN¥283.00k | sin datos | |
| Non-Executive Director | 2.9yrs | sin datos | sin datos | |
| Non-Executive Director | 1.2yrs | sin datos | sin datos |
4.9yrs
Permanencia media
55.5yo
Promedio de edad
Junta con experiencia: 3681's board of directors are considered experienced (4.9 years average tenure).